
01/10/2025
NICE has recommended durvalumab for limited-stage small-cell lung cancer in England, marking the first major advance in more than 20 years.
Health and Wellness media from www.onedaymd.com Health and Wellness site
No. 33-2, 2nd Floor, Jalan Tasik Utama 8, Trillium Lake Fields, Sungai Besi
Petaling Jaya
57000
Be the first to know and let us send you an email when One Day MD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.